Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J

Slides:



Advertisements
Similar presentations
Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions  Kathleen R. Bartemes, BA, Kate.
Advertisements

Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.
Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses  Katrien C. De Grove, MSc, Sharen Provoost,
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
Kiyoshi Yamazaki, MD, Joseph A. Murray, MD, Hirohito Kita, MD 
Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo  Jan Gutermuth, MD, Mayte Bewersdorff,
Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses  Anja Hänsel,
Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu  Amanda J. Reefer, MS, Kathryn.
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production  Laura Maggi, PhD, Gianni Montaini, BSc, Alessio Mazzoni,
Correlation of allergen-specific T follicular helper cell counts with specific IgE levels and efficacy of allergen immunotherapy  Yin Yao, MD, Cai-Ling.
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.
Reduced IFN-γ receptor expression and attenuated IFN-γ response by dendritic cells in patients with atopic dermatitis  Eva Gros, MSc, Susanne Petzold,
Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production  Mark C. Glaum, MD, PhD, Shilpi Narula, MD, Decheng Song,
Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL- 5 and IL-5 receptor levels  Miguel L. Stein, MD, Joyce M. Villanueva,
Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis  Kaori Mukai, PhD, Nicolas Gaudenzio,
Type 2 innate lymphoid cells in induced sputum from children with severe asthma  Prasad Nagakumar, MBBS, Laura Denney, PhD, Louise Fleming, MD, Andrew.
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells  Jun Young Hong, MS, J. Kelley.
Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Beate Rückert, Sci Tec, Tadech.
Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand  Junyan Han, PhD, Azzeddine.
Kiyoshi Yamazaki, MD, Joseph A. Murray, MD, Hirohito Kita, MD 
Glucocorticoids promote intrinsic human TH17 differentiation
Dawn C. Newcomb, PhD, Madison G
Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines  Maryam Salimi,
Human dendritic cell subset 4 (DC4) correlates to a subset of CD14dim/−CD16++ monocytes  Federica Calzetti, BS, Nicola Tamassia, PhD, Alessandra Micheletti,
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
Jovana Maric, MSc, Avinash Ravindran, MSc, Luca Mazzurana, MSc, Åsa K
Tacrolimus and TGF-β act synergistically on the generation of Langerhans cells  Bartlomiej Kwiek, MD, Wen-Ming Peng, MSc, Jean-Pierre Allam, MD, Andrzej.
Jerome A. Sigua, MD, Becky Buelow, MD, Dorothy S
Differential expression of functional chemokine receptors on human blood and lung group 2 innate lymphoid cells  Cathryn A. Weston, PhD, Batika M.J. Rana,
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin  Sucai Liu, PhD,
Katherine G. MacDonald, BSc, Nicholas A. J
Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen- presenting cells that induce proallergic T cells  Susanne Ebner, PhD,
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
Takao Kobayashi, PhD, Koji Iijima, PhD, Alexander L
Targeting Fel d 1 to FcγRI induces a novel variation of the TH2 response in subjects with cat allergy  Kathryn E. Hulse, BS, Amanda J. Reefer, MS, Victor.
Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor  Kathryn E. Hulse, PhD, Amanda J. Reefer,
Fibronectin is a TH1-specific molecule in human subjects
Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus–specific type 2 immune responses  Stephan Traidl, Petra Kienlin,
Β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung  Maya R. Karta, PhD, Peter S. Rosenthal,
A thymic stromal lymphopoietin–responsive dendritic cell subset mediates allergic responses in the upper airway mucosa  Guro R. Melum, MD, Lorant Farkas,
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Brent E. Palmer, PhD, Douglas G. Mack, PhD, Allison K
Zoulfia Allakhverdi, PhD, Michael R. Comeau, BSc, Dirk E
Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses  Katrien C. De Grove, MSc, Sharen Provoost,
Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired  Laurence Pellerin, PhD, Jennifer Anne Jenks,
Decreases in human dendritic cell–dependent TH2-like responses after acute in vivo IgE neutralization  John T. Schroeder, PhD, Anja P. Bieneman, BS, Kristin.
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Fibronectin is a TH1-specific molecule in human subjects
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease  Aurélie.
Yilin Qi, MSc, Darwin J. Operario, PhD, Christopher M
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsets  Martin Willheim,
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
Volume 33, Issue 5, Pages (November 2010)
Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells  Luzheng Xue, PhD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M
Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5− TH2 responses  Calman Prussin, MD, Joohee Lee,
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells by Ana Camelo, Guglielmo Rosignoli, Yoichiro.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
IL-10, TGF-β, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells  Noriko Ogasawara, MD, PhD, Julie A.
Regulation of IL-13 receptor α1 expression and signaling on human tonsillar B- lymphocyte subsets  Oumnia Hajoui, PhD, Huaien Zheng, MD, PhD, Julie Guay,
Taylor A. Doherty, MD, Rachel Baum, BS, Robert O
Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation  Venkateswara.
Alexander S. Kim, MD, Taylor A. Doherty, MD, Maya R
Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin  Soma.
Comparison of the allergic and nonallergic CD4+ T-cell responses to the major dog allergen Can f 1  Suvi Parviainen, MSc, Antti Taivainen, MD, PhD, Aino.
Presentation transcript:

Enhanced innate type 2 immune response in peripheral blood from patients with asthma  Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J. Fox, MD, Hirohito Kita, MD  Journal of Allergy and Clinical Immunology  Volume 134, Issue 3, Pages 671-678.e4 (September 2014) DOI: 10.1016/j.jaci.2014.06.024 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 IL-33 or IL-25 induce antigen-independent type 2 cytokine production by human PBMCs. PBMCs were cultured without antigen for 7 days with increasing concentrations of IL-33 (A) or IL-25 (B) in the presence or absence of 20 U/mL IL-2. IL-5 and IL-13 levels in the supernatants were determined by using ELISA. Data are the mean ± SEM of 30 subjects. *P < .05; **P < .01, compared with IL-2 alone or between groups as indicated by horizontal bars. C, PBMCs were cultured with medium, IL-33 alone (10 ng/mL), IL-25 alone (0.4 ng/mL), or in combination with IL-2 (20 U/mL), IL-7 (10 ng/mL), or TSLP (10 ng/mL). IL-5 levels in the supernatants were determined. Data are the mean ± SEM of 6 experiments. *P < .05 compared with IL-33 alone or IL-25 alone. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Lin− cells are necessary for IL-25- and IL-33–induced IL-13 production. PBMCs from subjects with AA and skin test-positive for house-dust mite (HDM) were separated into 2 fractions, the Lin+ with Lin− cell fraction and the Lin+ cell alone fraction. The Lin+ with Lin− cell fraction contained 82.0% Lin+ cells and 18.0% Lin− cells; the Lin+ cell alone fraction contained 99.5% Lin+ cells and 0.5% Lin− cells. The fractions were cultured with HDM extract (25 μg/mL), IL-25 or IL-33 (10 ng/mL) plus IL-2 (20 U/mL), or combinations of the HDM extract and cytokines for 7 days. A, IL-13 levels in cell-free supernatants of the Lin+ with Lin− cell fraction were determined. B, IL-13 levels in cell-free supernatants of the Lin+ cell alone fraction are presented as the ratio of the Lin+ cell alone fraction divided by the Lin+ with Lin− cell fraction from the same donor. Data are the mean ± SEM of 3 subjects. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Circulating ILC2s in peripheral blood respond to IL-33 ex vivo. A, Gating strategy to isolate ILC2s and other Lin− and Lin+ cell populations. Lin− lymphocytic cells were subdivided into 3 populations on the basis of CD127 and CRTH2 expression. Red boxes (labeled 1-4) indicate the sorted cells. B, Sorted cell populations from A were stimulated for 5 days with medium alone or IL-33 (10 ng/mL) plus IL-2 (20 U/mL). Levels of IL-5, IL-13, and IFN-γ in cell-free supernatants were measured using Milliplex. Data shown are the mean ± SEM of 3 independent experiments. **P < .01 compared with medium alone. C, ILC2s (Box 1 in A) were cultured for 5 days with IL-33 plus IL-2. Cell morphology is shown before and after culture by staining the cytospin preparations with Wright Giemsa. Scale bar = 10 μm. FSC, Forward scatter; SSC, side scatter. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 PBMCs from patients with AA show enhanced type 2 responses to IL-33 or IL-25. A, PBMCs from HC subjects, subjects with AR, or subjects with AA were cultured for 7 days with medium alone, IL-2 (20 U/mL) alone, IL-2 plus IL-33 (20 U/mL and 10 ng/mL, respectively), or IL-2 plus IL-25 (20 U/mL and 0.4 ng/mL, respectively). IL-5 (left) and IL-13 (right) levels in cell-free supernatants were determined using ELISA. Data shown are box and whisker plots (10th, 25th, 50th, 75th, and 90th percentile) of 14 or 15 subjects per group. *P < .05; **P < .01, between the groups indicated by horizontal bars. B, ILC2s in PBMCs were identified and enumerated using flow cytometry as described in Fig 2, A. Proportion of ILC2s in PBMCs and the total number of PBMCs per milliliter of blood are shown as the mean ± SEM (n = 6 per group). *P < .05, between the groups indicated by the horizontal bar. C, Total numbers of ILC2s per milliliter of blood were calculated. Each dot represents 1 patient, and horizontal bars indicate the mean for each group. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 CD3+ T cells are unnecessary for type 2 immune response to IL-25. Intact PBMCs (Intact) or PBMCs from which CD3+ cells had been magnetically depleted (CD3-depleted) were cultured with medium, IL-25 (10 ng/mL) alone, IL-2 (20 U/mL) alone, or IL-2 plus IL-25 for 5 days. IL-5 and IL-13 levels in cell-free supernatants were determined using ELISA. Data are the mean ± SEM of 2 to 5 independent experiments. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Blood ILC2s express the IL-33 receptor ST2 and respond to IL-33 in vitro. A, Gating strategy to identify ILC2s in PBMCs. In the histogram, anti-human ST2 staining (black line) and isotype control antibody staining (filled gray) are shown. B, PBMCs were cultured with medium alone or with IL-33 (10 ng/mL) plus IL-2 (20 U/mL) for 4 days. Brefeldin A was added for the last 12 hours. Top panels, Gating strategy for ILC2 identification. Bottom panels, Intracellular IL-5 staining in ILC2s cultured with medium alone (left panel, red line) or with IL-33 plus IL-2 (right panel, blue line) is shown. Gray-filled histograms depict isotype control staining for each culture condition. FSC, Forward scatter; SSC, side scatter. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Blood ILC2s from HC subjects and subjects with AA express comparable levels of ST2. PBMCs from the 2 subject groups were gated as described in Fig E2, and ST2 expression was analyzed. In the histogram, anti-human ST2 staining is indicated by the blue line and isotype control staining is depicted by the filled gray area. Representative data from 3 HC subjects and 3 subjects with AA are shown. Journal of Allergy and Clinical Immunology 2014 134, 671-678.e4DOI: (10.1016/j.jaci.2014.06.024) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions